Economic and Regional Development

May262016 by Pharmaceutical TechNo Comments

China Restructures its Drug Pricing Regime

Economic and Regional Development, Pharmaceutical Purchasing

In early May 2015, China’s National Development and Reform Commission (“NDRC”), together with six other agencies, issued aCircular Concerning Opinions on Advancing the Drug Pricing Reform (“Opinions”).1 The Opinions initiate a groundbreaking reform of the drug pricing system in China. Until now, pursuant to China’s Drug Administration Law and related policies and regulations, the government has either set specific prices, or set price ceilings, i.e., maximum retail prices (“MRPs”), for many drugs in China, including those that are reimbursed via its state- run insurance plans. The Opinions remove many of the constraints on drug prices, permitting those prices to be set by the market, and also provide some details of a planned reform to better set reimbursement standards and rates for drugs...

May192016 by Pharmaceutical TechNo Comments

Drugs Shortage and its Impact on Counterfeit Drugs

Drug Counterfeiting, Economic and Regional Development, Pharmaceutical Distribution and Logistics

Drugs Shortage Though the word shortage refers to the availability of less, its presence is not clinging to its meaning by swirling around the world with a strong presence, yet another area shadowing by 'shortage' is drugs. The world that has been witnessing the shortage of food and shelter is also taking into its account the shortage of drugs, several hospitals and pharmacies are heading into this dire problem and experiencing a gamut of serious health issues. If scarcity is drugs shortage renowned face then the other intimidating face is the raise of counterfeits. The short fall of drugs apparently become the lifeblood of thought to produce counterfeits which causes serious illness and sometimes even death can speak with the voice of counterfeit medicines. The usage of counterfeit drug...

Apr302016 by Pharmaceutical TechNo Comments

Productivity Ramps Up With Indian Pharmaceutical Cluster

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

Introduction The Indian Pharma Inc. ranks 5 in the pharma sector globally. The ranking is in terms of volume of production. This ranking and establishment accounts for 10% of global production and gives India recognition worldwide in the pharmaceutical sector. Considering the depth of the pharma industry in India, the turnover itself speaks of large numbers. During the 1980s what started as US $ 0.3 Million industry now proudly stands at a turnover of US $ 65 Billion. Considering the huge capital and turnover of the industry and according to the Department of Pharmaceuticals, the Indian pharmaceutical industry employs about 340,000 people and an estimated 400,000 doctors and 300,000 chemists. Industry structure The Indian pharmaceutical industry is fragmented with thousands of manufac...

Apr252016 by Pharmaceutical TechNo Comments

Canada to Donate Vaccine for Ebola to West Africa

Economic and Regional Development, Medicine, Vaccinations and Antidotes

By now, the Ebola virus has clasped its tentacles across West Africa and is beginning to show its tooth in the developed world. The Public Health Agency of Canada and the federal government have begun to share details about a vaccine that’s part of an experiment. The aim is to arrive at the Ebola vaccine which is supposed to be a donation to the people of Africa who have been subject Dr Gary Kobinger who is chief of the special pathogens at the agency as also the Heritage Minister Shelly Glover declared of such a development and made more information available at a news conference in Winnipeg recently. We have tried to accumulate as much information about the vaccine as we could- No. of doses that will be sent It has been made public that Canada will be donating anything between 800 to...

Apr102016 by Pharmaceutical TechNo Comments

What Can Recent Mergers Mean for the Future of Pharmaceutical Industry?

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

Expensive pharmaceutical deals in the industry are in a mad fury of alliances this year on account of the patent expiries that big drug companies are faced with. In an attempt to make up for the losses, hence, these companies are teaming up with their better off competitors. The world’s most well-known drug maker, Pfizer and London’s AstraZeneca have been heard to contemplate joining hands in a potential $100 billion epic merger which is a sign that the pharmaceutical sector is brimming with many more such deals in the days to come. Mergermarket, the famous research firm, shows data that suggest that five pharmacy deals valuing more than $2 billion in the first four months of 2014 are of the same momentum possibly, like seven deals of the same value that were announced in the entire year...

Apr72016 by Pharmaceutical TechNo Comments

Low-Cost Genome Sequencing

BioPharma, Biotechnology, Cheminformatics, Drug Development, Drug Discovery, Economic and Regional Development, Pharma Industry

In Silicon Valley, Moore's law appears to remained on equivalent balance with the regular laws classified by Isaac Newton. Intel prime supporter Gordon Moore's notorious perception that registering power has a tendency to twofold — and that its value hence parts — like clockwork has held valid for about 50 years with just minor update. Yet as a model of quick transform, it is the focus of energetic ill-use from genome analysts. In many presentations over the past few years, researchers have contrasted the slant of Moore's law and the quickly dropping expenses of DNA sequencing. For some time they kept pace, however since something like 2007, it has not even been close. The cost of sequencing a normal human genome has plunged from about Us$10 million to a couple of thousand dollars in only...

Mar312016 by Pharmaceutical TechNo Comments

Collaborations are a Secret Boon for the Pharma Industry in India

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

After it was recently announced that Bristol-Meyes Squibb and Astra Zenca ended their partnership and Aurobindo Pharma would acquire Dublin-based Actavis, the question on everyone’s minds seems to be, what next? The pharma industry has seen a double-growth in recent times owing to breakthrough patents in the field of cancer drugs and research. Therapies which are closely linked to winter related ailments, have posted strong double digit growths (such as respiratory at over 18.7 per cent, pain or analgesics at over 10.1 per cent), resulting in acute therapies growing faster than chronic segment, for the second consecutive month. For the full year 2013, the pharmaceutical market was reported at Rs 78,644 crore, with a growth of 9.9 per cent, over the same period last year. The Indian mark...

Mar302016 by Pharmaceutical TechNo Comments

Is South Africa Trying to delay Patents on New Medicines?

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Distribution and Logistics, Pharmaceutical Patenting

In a recent report by the Guardian, it was revealed that leaked documents showed lobbying proposals to delay laws that would allow fast introduction of generic medicines in South Africa. Shockingly, this means patents on breakthrough (read recently discovered medicine) drugs could be halted, but for what? If the changes to the new intellectual property law take place, this could be a definite reality, warns the Guardian. Drug companies in South Africa have been accused of planning a covert, well-funded campaign to delay the introduction of laws that threaten their profits. Leaked documents show that pharmaceutical companies planned a $450,000 campaign, involving a high-profile consultancy based in Washington, DC, against changes to intellectual property laws that would enable their pat...

Feb212016 by Pharmaceutical TechNo Comments

The Pivot of FDI in Indian Pharma

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

The department of industrial policy promotion (DIPP) is bringing new headwinds to the FDI (Foreign Direct Investment) in the sector of pharmaceuticals that looking for a review from it in regarding policies barely after its intervention from prime minister Clearance in months. The controversy rises here is regarding the FDI in retail to kick up the retail industry might bump back for time being, whereas another sector pharmaceuticals from FDI is quietly comes for UPA government clearance, which is going to hit common man pocket in future. States in India have some patent rights on the investor’s expenditure that spent on innovative research resources. These rights are granted for a certain period and during this period the owner solely can manufacture the drug by finding and fixing price...

Feb182016 by Pharmaceutical TechNo Comments

Reasons Behind Pharmaceutical Industry to Focus on Loyalty

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

For every industry maintaining relationship with the customers is the most benefitting factor and this is the reason behind adopting CRM for every industry. CRM for the pharmaceutical industry is one among those. Most of the companies are interested to automate their management process which helps to continuous engaging with their customers. CRM will help companies to get enduring relationship with customers and it is not only limited to existing customers, this also perfect platform to get connected with new customers. Marketing strategies of every company should change according to the current market conditions. Companies should focus on their market programs to turn into value oriented that would differentiate to get successful. Most importantly, leveraging customer loyalty is the key ...